Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anaptysbio Inc

21.35
+0.16500.78%
Volume:7.77K
Turnover:165.84K
Market Cap:654.58M
PE:-4.17
High:21.42
Open:21.10
Low:21.10
Close:21.18
Loading ...
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Feb 03, 2025

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Nov 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Correspondence

Form CORRESP - Correspondence
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities